Strongyloides ratti antigenic components recognized by IgE antibodies in immunoblotting as an additional tool for improving the immunodiagnosis in human strongyloidiasis

Memórias do Instituto Oswaldo Cruz

Rosângela Maria Rodrigues¹  Mônica Camargo Sopelete¹  Deise Aparecida De Oliveira Silva¹  Jair Pereira Cunha-júnior¹  Ernesto Akio Taketomi¹  Julia Maria Costa-cruz¹ 

[1],Universidade Federal de Uberlândia Instituto de Ciências Biomédicas Departamento de Imunologia, Microbiologia e ParasitologiaUberlândia MG ,Brasil

关键词: strongyloidiasis;    Strongyloides ratti;    IgE;    immunoblotting;    ELISA;   

DOI  :  10.1590/S0074-02762004000100016

来源: SciELO

【 摘 要 】

IgE antibody response in human strongyloidiasis was evaluated by enzyme-linked immunosorbent assay (ELISA) and immunoblotting (IB) using Strongyloides ratti saline extract as heterologous antigen. A total of 50 serum samples of patients who were shedding S. stercoralis larvae in feces (group I, copropositive), 38 of patients with other intestinal parasites (group II), and 38 of subjects with negative results in three parasitologic assays (group III, copronegative) were analyzed. Levels of IgE anti-Strongyloides expressed in ELISA Index (EI) were significantly higher in patients of group I (1.32) than in group II (0.51) and group III (0.81), with positivity rates of 54%, 0%, and 10.5%, respectively. Fifteen S. ratti antigenic components were recognized in IB-IgE by sera of group I, with frequency ranging from 8% to 46%. In group II, only two antigenic bands (101, 81 kDa) were detected in a frequency of 10% and no reactivity was found in group III. Sera with EI values > 1.5 recognized five from 13 specific antigenic bands (70, 63, 61, 44, 7 kDa). It can be concluded that these five antigenic components recognized by IB-IgE using S. ratti antigen might be employed as an additional tool for improving the immunodiagnosis in human strongyloidiasis.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License